Medline (Nasdaq:MDLN) has received a warning letter from the FDA related to NAMIC brand angiographic control syringes and manifolds.
While advances in modern technology have allowed average people access to tremendous computing power as well as novel tools like 3D printers and laser cutters for a bare minimum cost, around here we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results